title: The role of dietary zinc in modifying the onset and severity of spontaneous diabetes in the BB Wistar rat.
abstract: The goal of this study was to determine whether zinc supplementation in the diet of diabetes-prone BB Wistar rats will delay or prevent the onset of overt diabetes. Male Wistar BB rats were fed diets containing either 1000 ppm (HZ), 50 ppm (NZ), or 1 ppm zinc (LZ) starting at 30 days of age. Non-diabetes-prone rats were fed NZ and designated as controls (NORM). Beginning at 60 days, the rats were checked for glycosuria and, if positive, were given an i.p. glucose tolerance test (IPGTT). All remaining animals underwent an IPGTT at 100 days and were sacrificed. At 90 days of age HZ rats had a lower incidence of diabetes (19%) than NZ (53%) or LZ (44%) animals (P < 0.015). By age 100 days, for the HZ group, there was a 60% reduction in the number of expected overt diabetic rats. HZ animals also had higher concentrations of both pancreatic and serum insulin and exhibited lower serum glucose and triglycerides. Immunohistochemistry of HZ rats was clearly different from NZ rats and showed evidence of nearly normal pancreatic endocrine activity. Data indicate that dietary treatment of diabetes-prone BB Wistar rats with zinc appears to be an effective approach for delaying or preventing the onset of diabetes in genetically predisposed rodents. This finding may suggest further experimental studies regarding dietary means for preservation of pancreatic function.
authors.affiliation: Department of Pediatrics, North Shore University Hospital-New York University School of Medicine, Manhasset 11030, USA.
authors.forename: M H
authors.initials: MH
authors.lastname: Tobia
authors.forename: M M
authors.initials: MM
authors.lastname: Zdanowicz
authors.forename: M A
authors.initials: MA
authors.lastname: Wingertzahn
authors.forename: B
authors.initials: B
authors.lastname: McHeffey-Atkinson
authors.forename: A E
authors.initials: AE
authors.lastname: Slonim
authors.forename: R A
authors.initials: RA
authors.lastname: Wapnir
mesh_terms: D000293:Adolescent; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D002784:Cholesterol / Q000097:blood; D003300:Copper / Q000032:analysis / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000517:prevention & control*; D004032:Diet; D004305:Dose-Response Relationship, Drug; D005951:Glucose Tolerance Test; D006801:Humans; D007150:Immunohistochemistry; D007328:Insulin / Q000032:analysis / Q000097:blood; D007515:Islets of Langerhans / Q000473:pathology; D008297:Male; D010179:Pancreas / Q000378:metabolism / Q000473:pathology; D051381:Rats; D011913:Rats, Inbred BB; D014280:Triglycerides / Q000097:blood; D015430:Weight Gain; D015032:Zinc / Q000008:administration & dosage / Q000032:analysis / Q000627:therapeutic use*
chemical_list: D001786:Blood Glucose; D007328:Insulin; D014280:Triglycerides; D003300:Copper; D002784:Cholesterol; D015032:Zinc